// App-Quantinova.ai

1006 : Novel adjuvants in triple negative breast cancer chemotherapy

Researchers

Presenter

  • Antonio Rampoldi

Principal Investigators

  • Adriana Harbuzariu

  • Tia L. Harmon

  • Ruben R. Gonzalez-Perez

Medical Centers

  • Morehouse School of Medicine, Atlanta, GA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

  • Obesity

  • Solid malignancies

Biomarkers

  • Leptin

  • Leptin receptor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved